Publikationen in Zusammenarbeit mit Forschern von University Medical Center Freiburg (16)

2022

  1. High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis

    Blood, Vol. 139, Núm. 10, pp. 1557-1563

2021

  1. Red blood cell fatty acids and risk of colorectal cancer in the European Prospective investigation into cancer and nutrition (EPIC)

    Cancer Epidemiology Biomarkers and Prevention, Vol. 30, Núm. 5, pp. 874-885

2020

  1. Healthy lifestyle and the risk of lymphoma in the European Prospective Investigation into Cancer and Nutrition study

    International Journal of Cancer, Vol. 147, Núm. 6, pp. 1649-1656

  2. Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study

    International Journal of Cancer, Vol. 147, Núm. 5, pp. 1315-1324

2019

  1. Reproductive Factors, Exogenous Hormone Use, and Risk of B-Cell Non-Hodgkin Lymphoma in a Cohort of Women from the European Prospective Investigation into Cancer and Nutrition

    American Journal of Epidemiology, Vol. 188, Núm. 2, pp. 274-281

2015

  1. Determinants of the t(14;18) translocation and their role in t(14;18)-positive follicular lymphoma

    Cancer Causes and Control, Vol. 26, Núm. 12, pp. 1845-1855

  2. Lag times between lymphoproliferative disorder and clinical diagnosis of chronic Lymphocytic Leukemia: A prospective analysis using plasma soluble CD23

    Cancer Epidemiology Biomarkers and Prevention, Vol. 24, Núm. 3, pp. 538-545

2014

  1. Dietary intakes and risk of lymphoid and myeloid leukemia in the european prospective investigation into cancer and nutrition (EPIC)

    Nutrition and Cancer, Vol. 66, Núm. 1, pp. 14-28

  2. Mitochondrial DNA copy number and future risk of B-cell lymphoma in a nested case-control study in the prospective EPIC cohort

    Blood, Vol. 124, Núm. 4, pp. 530-535

  3. Prediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myeloma-results of the European Prospective Investigation into Cancer and Nutrition

    Carcinogenesis, Vol. 35, Núm. 12, pp. 2716-2722

  4. Prediagnostic telomere length and risk of B-cell lymphoma-results from the epic cohort study

    International Journal of Cancer, Vol. 135, Núm. 12, pp. 2910-2917

  5. t(14;18) translocation: A predictive blood biomarker for follicular lymphoma

    Journal of Clinical Oncology, Vol. 32, Núm. 13, pp. 1347-1355

2013

  1. Plasma 25-hydroxyvitamin D concentration and lymphoma risk: Results of the european prospective investigation into cancer and nutrition

    American Journal of Clinical Nutrition, Vol. 98, Núm. 3, pp. 827-838

2012

  1. Genome-wide association study of classical hodgkin lymphoma and epstein-barr virus status-defined subgroups

    Journal of the National Cancer Institute, Vol. 104, Núm. 3, pp. 240-253

  2. Inflammation marker and risk of pancreatic cancer: A nested case-control study within the EPIC cohort

    British Journal of Cancer, Vol. 106, Núm. 11, pp. 1866-1874

  3. The associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: A case-control study within the prospective EPIC cohort

    Cancer Epidemiology Biomarkers and Prevention, Vol. 21, Núm. 4, pp. 619-628